XLON
SAG
Market cap308mUSD
Oct 09, Last price
570.00GBP
1D
-0.52%
1Q
-2.56%
Jan 2017
258.49%
IPO
1,325.00%
Name
Science Group PLC
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Science Group plc is an international consulting firm based in Cambridge, UK, offering specialized science and technology services across the United Kingdom, North America, Europe, and other global markets. The company operates through three main divisions: R&D Consultancy, Regulatory & Compliance, and Frontier Smart Technologies. Their core offerings include product and technology development, expert scientific and regulatory advice, and comprehensive registration and compliance services, serving a wide array of sectors such as medical, food and beverage, consumer, industrial, chemical, and energy. In addition to its consultancy work, Science Group plc manages property services and manufactures and sells integrated circuits and modules for digital radio applications. The company, originally incorporated as Sagentia Group plc in 2008, rebranded to Science Group plc in July 2015.
Related entities
Subsidiaries (4)
CRITICAL MARITIME SYSTEMS & SUPPORT LIMITED
QUADRO EPSOM LIMITED
QUADRO HARSTON LIMITED
SAGENTIA LIMITED
Key people
Executive Chairman of the Board · since 2012
Jon Brett
Group Finance Director, Executive Director · since 2022
Daniel Edwards
Group Managing Director, Executive Director · since 2019
Company Secretary · since 2013
Senior Non-Executive Independent Director · since 2023
Susan Davies
Non-Executive Independent Director · since 2022
Headquarters & legal address
HARSTON MILL ROYSTON ROAD
HARSTON
CAMBRIDGE, CAM CB22 7GG
GB
HARSTON
CAMBRIDGE, CAM CB22 7GG
GB
Valuation
Title GBP in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||